Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Am J Psychiatry

Retrieve available abstracts of 31 articles:
HTML format

Single Articles

    November 2022
  1. JONAS KG, Fochtmann LJ, Perlman G, Kane JM, et al
    Distinguishing the Effects of Lead-Time Bias and Duration of Untreated Psychosis.
    Am J Psychiatry. 2022;179:862-863.

    Early-Onset Psychosis and Autism Spectrum Disorder: Similar Rates of Deleterious Copy Number Variants, Yet Diverse Phenotypic Manifestations.
    Am J Psychiatry. 2022;179:798-799.

    Polygenic Risk Scores and Genetics in Psychiatry.
    Am J Psychiatry. 2022;179:781-784.

  4. O'KEEFFE D, Kinsella A, Waddington JL, Clarke M, et al
    Distinguishing the Effects of Lead-Time Bias and Duration of Untreated Psychosis: Reply to Jonas et al.
    Am J Psychiatry. 2022;179:863-864.

  5. SIGSTROM R, Kowalec K, Jonsson L, Clements CC, et al
    Association Between Polygenic Risk Scores and Outcome of ECT.
    Am J Psychiatry. 2022;179:844-852.
    PubMed     Abstract available

    October 2022
  6. SOLMI M, Taipale H, Holm M, Tanskanen A, et al
    Effectiveness of Antipsychotic Use for Reducing Risk of Work Disability: Results From a Within-Subject Analysis of a Swedish National Cohort of 21,551 Patients With First-Episode Nonaffective Psychosis.
    Am J Psychiatry. 2022 Oct 6:appiajp21121189. doi: 10.1176/appi.ajp.21121189.
    PubMed     Abstract available

    September 2022
  7. GREGERSEN M, Mollegaard Jepsen JR, Rohd SB, Sondergaard A, et al
    Developmental Pathways and Clinical Outcomes of Early Childhood Psychotic Experiences in Preadolescent Children at Familial High Risk of Schizophrenia or Bipolar Disorder: A Prospective, Longitudinal Cohort Study - The Danish High Risk and Resilience
    Am J Psychiatry. 2022;179:628-639.
    PubMed     Abstract available

  8. COTTER D, Healy C, Staines L, Mongan D, et al
    Broadening the Parameters of Clinical High Risk for Psychosis.
    Am J Psychiatry. 2022;179:593-595.

    August 2022
  9. BROWNSTEIN CA, Douard E, Mollon J, Smith R, et al
    Similar Rates of Deleterious Copy Number Variants in Early-Onset Psychosis and Autism Spectrum Disorder.
    Am J Psychiatry. 2022 Aug 24:appiajp21111175. doi: 10.1176/appi.ajp.21111175.
    PubMed     Abstract available

    June 2022
  10. PAUL SM, Yohn SE, Popiolek M, Miller AC, et al
    Muscarinic Acetylcholine Receptor Agonists as Novel Treatments for Schizophrenia.
    Am J Psychiatry. 2022 Jun 27:appiajp21101083. doi: 10.1176/appi.ajp.21101083.
    PubMed     Abstract available

    April 2022
  11. CHAND GB, Singhal P, Dwyer DB, Wen J, et al
    Schizophrenia Imaging Signatures and Their Associations With Cognition, Psychopathology, and Genetics in the General Population.
    Am J Psychiatry. 2022 Apr 12:appiajp21070686. doi: 10.1176/appi.ajp.21070686.
    PubMed     Abstract available

  12. O'KEEFFE D, Kinsella A, Waddington JL, Clarke M, et al
    20-Year Prospective, Sequential Follow-Up Study of Heterogeneity in Associations of Duration of Untreated Psychosis With Symptoms, Functioning, and Quality of Life Following First-Episode Psychosis.
    Am J Psychiatry. 2022;179:288-297.
    PubMed     Abstract available

  13. CHUNG DW, Geramita MA, Lewis DA
    Synaptic Variability and Cortical Gamma Oscillation Power in Schizophrenia.
    Am J Psychiatry. 2022;179:277-287.
    PubMed     Abstract available

  14. KALIN NH
    Integrating Clinical and Basic Research: Opioid Use Disorder, Psychotic Illnesses, and Prefrontal Microcircuits Relevant to Schizophrenia.
    Am J Psychiatry. 2022;179:255-258.

  15. MALLA A
    Reducing Duration of Untreated Psychosis: The Neglected Dimension of Early Intervention Services.
    Am J Psychiatry. 2022;179:259-261.

  16. SOHAL VS
    Transforming Discoveries About Cortical Microcircuits and Gamma Oscillations Into New Treatments for Cognitive Deficits in Schizophrenia.
    Am J Psychiatry. 2022;179:267-276.
    PubMed     Abstract available

    March 2022
  17. MANCINI V, Rochas V, Seeber M, Roehri N, et al
    Aberrant Developmental Patterns of Gamma-Band Response and Long-Range Communication Disruption in Youths With 22q11.2 Deletion Syndrome.
    Am J Psychiatry. 2022;179:204-215.
    PubMed     Abstract available

    January 2022
  18. GANESH S, D'Souza DC
    Cannabis and Psychosis: Recent Epidemiological Findings Continuing the "Causality Debate".
    Am J Psychiatry. 2022;179:8-10.

  19. SANCHEZ-RICO M, Limosin F, Hoertel N
    Is a Diagnosis of Schizophrenia Spectrum Disorder Associated With Increased Mortality in Patients With COVID-19?
    Am J Psychiatry. 2022;179:71-73.

    October 2021
  20. KALIN NH
    Depression and Schizophrenia: Sleep, Medical Risk Factors, Biomarkers, and Treatment.
    Am J Psychiatry. 2021;178:881-884.

    Do the Benefits of Early Intervention Services for Psychosis Generalize and Persist in the Real World?
    Am J Psychiatry. 2021;178:890-892.

    September 2021
  22. KALIN NH
    Insights Into Improving Clinical Outcomes Across Psychiatric Disorders and Medical Comorbidities.
    Am J Psychiatry. 2021;178:779-782.

    August 2021
  23. PARKER DA, Trotti RL, McDowell JE, Keedy SK, et al
    Auditory Oddball Responses Across the Schizophrenia-Bipolar Spectrum and Their Relationship to Cognitive and Clinical Features.
    Am J Psychiatry. 2021 Aug 19:appiajp202120071043.
    PubMed     Abstract available

    July 2021
  24. POSSELT CM, Albert N, Nordentoft M, Hjorthoj C, et al
    The Danish OPUS Early Intervention Services for First-Episode Psychosis: A Phase 4 Prospective Cohort Study With Comparison of Randomized Trial and Real-World Data.
    Am J Psychiatry. 2021 Jul 28:appiajp202120111596.
    PubMed     Abstract available

  25. WEISER M, Davis JM, Brown CH, Slade EP, et al
    Differences in Antipsychotic Treatment Discontinuation Among Veterans With Schizophrenia in the U.S. Department of Veterans Affairs.
    Am J Psychiatry. 2021 Jul 14:appiajp202020111657.
    PubMed     Abstract available

    Changing the Face of Schizophrenia.
    Am J Psychiatry. 2021;178:584-585.

    May 2021
  27. JOSHI YB, Thomas ML, Braff DL, Green MF, et al
    Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia.
    Am J Psychiatry. 2021 May 14:appiajp202020081212.
    PubMed     Abstract available

  28. ANGLIN DM, Ereshefsky S, Klaunig MJ, Bridgwater MA, et al
    From Womb to Neighborhood: A Racial Analysis of Social Determinants of Psychosis in the United States.
    Am J Psychiatry. 2021 May 3:appiajp202020071091.
    PubMed     Abstract available

  29. HONER WG
    Better Evidence for Pharmacological Maintenance Treatment in Nonaffective Psychoses: Implications for Relapse Prevention.
    Am J Psychiatry. 2021;178:369-371.

  30. FERRARELLI F, Phillips ML
    Examining and Modulating Neural Circuits in Psychiatric Disorders With Transcranial Magnetic Stimulation and Electroencephalography: Present Practices and Future Developments.
    Am J Psychiatry. 2021;178:400-413.
    PubMed     Abstract available

    April 2021
  31. AMSALEM D, Markowitz JC, Jankowski SE, Yang LH, et al
    Sustained Effect of a Brief Video in Reducing Public Stigma Toward Individuals With Psychosis: A Randomized Controlled Trial of Young Adults.
    Am J Psychiatry. 2021 Apr 26:appiajp202020091293.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.